The occurrence of asthma in an extensive-stage small-cell lung cancer patient after combination therapy with atezolizumab and anlotinib: a case report

The occurrence of asthma in an extensive-stage small-cell lung cancer patient after combination therapy with atezolizumab and anlotinib: a case report

BackgroundExtensive-stage small-cell lung cancer (ES-SCLC) is highly malignant, with early metastasis and high recurrence. Since therapeutic options are limited, ES-SCLC has a characteristically short survival period and extremely poor prognosis. A combination of immune checkpoint inhibitors (ICIs)...

Full description

Bibliographic Details
Main Authors: Wang Deng, Juan Chen, Xin-Yu Deng
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Immunology
Subjects:
atezolizumab
anlotinib
asthma
small-cell lung cancer
combined regimens
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1333850/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1333850/full

Similar Items